This trial will test the effects of psilocybin on migraine headaches. Subjects will keep a headache diary before, during, and after treatment.
8 Primary · 8 Secondary · Reporting Duration: From two weeks before first session to three months after second session using a headache diary
24 Total Participants · 4 Treatment Groups
Primary Treatment: Low Dose Psilocybin · Has Placebo Group · Phase 1
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||80.0%|
|VA Connecticut Healthcare System, West Haven Campus||100.0%|
|Did not meet criteria||20.0%|